Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Interest & Investment Income (2023 - 2025)

Cross Country Healthcare's Interest & Investment Income history spans 3 years, with the latest figure at $882000.0 for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 81.86% year-over-year to $882000.0; the TTM value through Dec 2025 reached $3.1 million, up 56.45%, while the annual FY2025 figure was $3.1 million, 56.45% up from the prior year.
  • Interest & Investment Income reached $882000.0 in Q4 2025 per CCRN's latest filing, up from $864000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.1 million in Q3 2024 to a low of $5000.0 in Q3 2023.
  • Average Interest & Investment Income over 3 years is $520500.0, with a median of $583000.0 recorded in 2024.
  • Peak YoY movement for Interest & Investment Income: surged 22040.0% in 2024, then decreased 21.95% in 2025.
  • A 3-year view of Interest & Investment Income shows it stood at $71000.0 in 2023, then surged by 583.1% to $485000.0 in 2024, then skyrocketed by 81.86% to $882000.0 in 2025.
  • Per Business Quant, the three most recent readings for CCRN's Interest & Investment Income are $882000.0 (Q4 2025), $864000.0 (Q3 2025), and $702000.0 (Q2 2025).